← TrialMatch
HomeTrials

Randomized Controlled Trial of the Mindful Compassion Care Program in Reducing Psychologic

Recent studies have shown that nurses have been more affected by the COVID-19 pandemic than any other group of hospital workers in terms of anxiety, depression, and burnout. Several clinical studies had previously demonstrated the effectiveness of mindfulness and compassion interventions in reducing burnout and emotion

Condition(s)Burnout, COVID-19
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryRecent studies have shown that nurses have been more affected by the COVID-19 pandemic than any other group of hospital workers in terms of anxiety, depression, and burnout. Several clinical studies had previously demonstrated the effectiveness of mindfulness and compassion interventions in reducing burnout and emotional distress amongst healthcare professionals. A parallel-group randomized controlled trial will assess the feasibility, acceptability, and efficacy of a mindfulness and compassion-focused programme on frontline nurses who had been working during the COVID-19 pandemic. Seventy-two participants will be divided equally into an intervention group and a control group. Primary outcome will be assessed using the Emotional Exhaustion subscale of the Maslach Burnout Inventory General
Who can participateInclusion Criteria: To be included in the study, a participants will have to be: * a nurse employed at AOUI for the past two years; * working within intensive care units, infectious disease unit, pulmonary medicine and internal medicine units that have been converted to COVID-19 sub-intensive units; * scoring above the cut-off score for the Emotional Exhaustion sub-scale (EX) of the MBI-GS (equal to or greater than 2.20) in accordance with Italian norms Exclusion Criteria: Respondents will be excluded if they: * have participated in mindfulness-based interventions in the previous 6 months; * show a score \< 2.20 in the EX subscale of the MBI-GS; * are receiving psychosocial or psychiatric treatment. Participants allocated to the WL will be requested not to participate in a mindfulness cour
Ages25 Years to 65 Years
SexAll
Lead sponsorUniversita di Verona
LocationsVerona, Italia, Italy
Start date2023-01-27
NCT IDNCT05308537
Official listinghttps://clinicaltrials.gov/study/NCT05308537

🔍 Search all trials →